CHARITY CLAYTON: Open Payments
NPI 1790438653 · HARRISON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,429 in 62 payments from 13 companies in 2025. Trend: 2023 $1,205 · 2024 $1,236 · 2025 $1,429
Food & beverage: $1,429
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $341 |
| AstraZeneca Pharmaceuticals LP | 7 | $256 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $191 |
| GlaxoSmithKline, LLC. | 3 | $155 |
| PFIZER INC. | 7 | $136 |
| Lilly USA, LLC | 6 | $103 |
| ABBVIE INC. | 4 | $78 |
| Xeris Pharmaceuticals, Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Inspire Medical Systems, Inc. | 2 | $36 |
Products named: CAPLYTA, Ozempic, AIRSUPRA, AREXVY, Rybelsus, FARXIGA, MOUNJARO, PREVNAR 20.
Industry payments across TN — which companies pay providers there.
